About Exquiron
Exquiron is a company based in Reinach (Switzerland) founded in 2012 was acquired by Aptuit in April 2016. Exquiron operates in a competitive market with competitors including Gubra, Tigermed, BioQual, Gentronix and Shanghai Semero Biotechnology, among others.
- Headquarter Reinach, Switzerland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Exquiron
Detailed funding history for Exquiron
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Exquiron
Exquiron has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Aptuit.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Contract research and development services for small molecules are offered.
|
Locked | Locked | Locked |
Investor details for Exquiron
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Exquiron
Investment portfolio details for Exquiron
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Exquiron
Detailed financials for Exquiron
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Exquiron Comparisons
Peer comparison for Exquiron
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Exquiron
Exquiron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gubra, Tigermed, BioQual, Gentronix and Shanghai Semero Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided.
|
|
| Locked | Locked | Locked |
Drug development and preclinical services are provided by Tigermed.
|
|
| Locked | Locked | Locked |
Contract research on infectious disease models is conducted.
|
|
| Locked | Locked | Locked |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| Locked | Locked | Locked |
Diversified preclinical services for brain-related disorders are provided.
|
|
| Locked | Locked | Locked |
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
|
Detailed competitors of Exquiron
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Exquiron
Complete news archive for Exquiron
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Exquiron
Exquiron was founded in 2012.
Exquiron is headquartered in Reinach, Switzerland. It is registered at Reinach, Basel-landschaft, Switzerland.
Exquiron was founded in 2012 in Reinach, Switzerland, as a contract research organization focused on the pharmaceutical sector. Services encompass assay development, high-throughput screening, screening libraries, SAR expansion, hit profiling, and in silico drug discovery for early-stage projects. The company was acquired by Aptuit LLC in April 2016, integrating its operations into broader clinical research capabilities.
Exquiron has 1 investor. Key investors include Aptuit.